- Published on:
Havana, Jul 18 (Prensa Latina) Abdala, Cuba's and Latin America's first vaccine against Covid-19, demonstrated a 100-percent efficacy during in its third phase of clinical trial in thwarting severe systemic disease and deaths, its creators informed recently.
